Drugs / CD80 breast cancer vaccine
last change Jul 2003 re-read 2 minutes ago

CD80 breast cancer vaccine

Developed for
breast cancer
Investigated by
National Cancer Institute (NCI)

Trials 1 · a red edge is where a trial was stopped

19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00003184 Aug 1996 → Jul 2003 breast cancer National Cancer Institute (NCI) Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CD80 breast cancer vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00003184
Action Deplete “Vaccines made from breast cancer cells may make the body build an immune response to kill tumor cells.” NCT00003184